Xpovio Approval Sought for Myeloma Indications in 3 Asian Pacific Markets
News
Antengene is asking health authorities in Singapore, Australia, and Hong Kong to approve Xpovio (selinexor) for the treatment of multiple myeloma, the company announced in a press release. Specifically, ... Read more